Dengue Fever
Submitted by: Barkat Ali
Roll Number: 15032069
Institute: FUUAST
Table of Contents
1. INTRODUCTION
2. CAUSATIVE AGENT
3. VECTOR BIOLOGY
4. TRANSMISSION CYCLE
5. EPIDEMIOLOGY
6. PATHOPHYSIOLOGY
7. CLINICAL MANIFESTATIONS
8. DIAGNOSIS
9. TREATMENT & MANAGEMENT
10. PREVENTION & CONTROL
11. CONCLUSION
12. REFERENCES
Chapter 1: Introduction
DENGUE FEVER is one of the most significant mosquito-borne viral diseases
affecting humans in the 21st century. It is caused by the dengue virus, which
belongs to the Flavivirus genus, and is primarily transmitted through the bite
of the Aedes aegypti mosquito. The disease has emerged as a global public
health problem, particularly in tropical and subtropical regions where climatic
and environmental conditions support the breeding of its mosquito vector.
According to the World Health Organization (WHO), dengue fever is now
endemic in more than 100 countries, putting nearly half of the world’s
population at risk.
Historical Background:
The first recognized outbreak of dengue-like illness was documented in 1780
in Philadelphia, United States. However, the disease became more prominent
in the 20th century, when large-scale epidemics were reported in Southeast
Asia during and after World War II. Over the decades, rapid urbanization,
population growth, poor sanitation, and increased travel have contributed to
the spread of dengue across continents.
Global and Local Importance:
Globally, dengue infects an estimated 390 million people every year, of
which around 96 million manifest clinically with symptoms. Severe forms of
the disease, such as Dengue Hemorrhagic Fever (DHF) and Dengue Shock
Syndrome (DSS), can lead to life-threatening complications, particularly
among children. The absence of a specific antiviral treatment and limited
effectiveness of existing vaccines further intensify the importance of
preventive strategies.
In Pakistan, dengue fever has emerged as a recurring epidemic over the last
two decades. The first major outbreak occurred in 1994 in Karachi, but the
most devastating waves were observed in 2011 and 2019, particularly in
Punjab and Sindh provinces. Thousands of cases are reported annually, with
peaks during and after the monsoon season, when stagnant water creates
ideal breeding grounds for Aedes mosquitoes. The disease not only burdens
healthcare systems but also disrupts social and economic activities, as
affected individuals require medical care and recovery time.
Relevance of the Study:
Studying dengue fever is critical due to its increasing prevalence and the
lack of definitive treatment. Understanding its causative agent, vector
biology, transmission cycle, and pathophysiology provides a foundation for
effective control and prevention measures. Moreover, awareness about
clinical manifestations and timely diagnosis can significantly reduce
morbidity and mortality. In the context of Pakistan, where recurrent
outbreaks strain the healthcare infrastructure, this study holds particular
importance for public health planning and policy-making.
Chapter 2: Causative Agent
Dengue fever is caused by the dengue virus (DENV), a member of the
Flaviviridae family and Flavivirus genus. It is an RNA virus that shares
structural and genetic similarities with other flaviviruses such as Zika virus,
Yellow Fever virus, and West Nile virus. Dengue virus is the most widespread
arbovirus (arthropod-borne virus) affecting humans worldwide.
Types of Dengue Virus
There are five known serotypes of dengue virus, classified as:
DEN-1
DEN-2
DEN-3
DEN-4
DEN-5 (discovered in 2013 in Malaysia, less common but capable of causing
outbreaks)
All serotypes are antigenically distinct, meaning infection with one serotype
provides lifelong immunity against that particular type but only temporary
cross-immunity against the others. Subsequent infections with a different
serotype increase the risk of developing severe forms of dengue, such as
Dengue Hemorrhagic Fever (DHF) or Dengue Shock Syndrome (DSS).
Structure of the Virus
The dengue virus is approximately 50 nanometers in diameter and has a
spherical shape. It consists of:
A single-stranded positive-sense RNA genome, about 10.7 kilobases long.
Three structural proteins:
C (capsid protein) – protects the viral RNA.
M (membrane protein) – involved in viral assembly.
E (envelope protein) – responsible for host cell binding and immune
recognition.
Seven non-structural proteins (NS1 to NS5) that play roles in viral replication
and immune system evasion.
Replication in Host Cells
Once introduced into the human body through a mosquito bite, the dengue
virus binds to receptors on host cells, particularly immune cells such as
monocytes and macrophages. The virus enters via endocytosis, releases its
RNA genome, and hijacks the host’s cellular machinery to produce viral
proteins and replicate new viral particles. These newly formed viruses are
then released into the bloodstream, causing widespread infection.
Significance of Multiple Serotypes
The presence of multiple serotypes is a major challenge in controlling dengue
fever. Secondary infections with a different serotype often result in antibody-
dependent enhancement (ADE), where pre-existing antibodies from the first
infection facilitate viral entry into immune cells. This mechanism increases
viral load and is linked to severe disease outcomes, including DHF and DSS.
Chapter 3: Vector Biology
The transmission of dengue fever is closely linked to its primary vector, the
Aedes aegypti mosquito. Understanding the biology, behavior, and breeding
patterns of this mosquito is critical for developing effective control and
prevention strategies. Although Aedes albopictus (the Asian tiger mosquito)
can also transmit dengue, Aedes aegypti remains the most important vector
worldwide.
Identification and Characteristics of Aedes aegypti:
The Aedes aegypti mosquito has distinct physical features that make it easy
to identify:
Small to medium-sized, black in color with white markings on its legs and
body.
A lyre-shaped pattern of silver-white scales on the upper thorax.
Unlike many other mosquito species, Aedes aegypti is a daytime biter, most
active during early morning and late afternoon.
It prefers to rest indoors, especially in dark, humid areas such as under
furniture or inside closets.
Feeding Behavior:
The female mosquito requires a blood meal to develop eggs, and humans are
the preferred hosts. Aedes aegypti is a multiple feeder, meaning that one
mosquito can bite several people in a short period. This behavior significantly
enhances the spread of dengue virus in densely populated areas. Males do
not bite and feed only on nectar and plant juices.
Breeding Habits:
Aedes aegypti breeds in artificial water containers commonly found in and
around human settlements. Unlike rural malaria-transmitting mosquitoes,
this species thrives in urban environments. Common breeding sites include:
Discarded tires, cans, and bottles.
Water storage tanks, flower pots, and buckets.
Clogged drains and gutters.
Any stagnant water that remains undisturbed for 7–10 days.
Eggs are remarkably resilient. They can withstand desiccation for months
and hatch when they come into contact with water, allowing the species to
survive dry seasons and reappear after rains.
Life Cycle of Aedes aegypti:
The mosquito undergoes four distinct stages in its life cycle:
1. Egg – Laid on damp surfaces just above the waterline; hatch when
submerged in water.
2. Larva – Aquatic, worm-like, feeds on microorganisms in water.
3. Pupa – Non-feeding, transitional stage where metamorphosis occurs.
4. Adult – Emerges as a flying mosquito; lifespan ranges from 2–4 weeks.
The entire cycle can be completed within 7–10 days under favorable
conditions, making the mosquito capable of multiplying rapidly during the
rainy season.
Role in Disease Transmission:
The Aedes aegypti mosquito becomes infected when it bites a person
already carrying the dengue virus in their bloodstream. After ingestion, the
virus multiplies inside the mosquito’s midgut and spreads to its salivary
glands. This process, known as the extrinsic incubation period (EIP), usually
takes 8–12 days depending on temperature and environmental conditions.
Once infectious, the mosquito can transmit the virus to humans for the rest
of its life.
Vector Adaptability:
One of the reasons dengue is difficult to control is the adaptability of Aedes
aegypti. This mosquito has:
A strong preference for urban environments.
The ability to breed in very small water collections, often inside homes.
Behavioral resilience, such as hiding indoors and resting in shaded places,
which makes insecticide spraying less effective.
Chapter 4: Transmission Cycle
The transmission of dengue fever involves a complex interaction between
humans, mosquitoes, and the dengue virus. The primary vector, Aedes
aegypti, plays a crucial role in maintaining and spreading the virus within
human populations. Understanding the transmission cycle is essential for
controlling outbreaks and preventing epidemics.
Human ↔ Mosquito Relationship:
The cycle begins when a female Aedes aegypti mosquito bites an infected
human who has the dengue virus circulating in their bloodstream. The virus
enters the mosquito’s midgut and, after an extrinsic incubation period (8–12
days), migrates to the mosquito’s salivary glands. Once infectious, the
mosquito can transmit the virus during subsequent bites.
When the mosquito bites another human, the virus is injected into the
bloodstream along with the mosquito’s saliva. The virus then infects white
blood cells and spreads throughout the body, leading to the clinical
symptoms of dengue fever.
Epidemic Cycle:
The epidemic cycle of dengue is influenced by three major factors:
1. Vector density – A high population of Aedes mosquitoes increases the
chances of transmission.
2. Human mobility – Movement of infected individuals spreads the virus
to new areas where competent vectors exist.
3. Environmental conditions – Warm temperatures, rainfall, and urban
crowding accelerate mosquito breeding and viral transmission.
Epidemics often occur in waves, with peaks during rainy seasons when
breeding sites proliferate.
Urban vs. Rural Transmission:
Urban areas: Transmission is more intense due to high population density,
poor sanitation, and abundant artificial breeding sites. Cities such as Karachi,
Lahore, and Rawalpindi are hotspots for outbreaks in Pakistan.
Rural areas: Transmission is less common but still possible, especially where
water storage practices create mosquito habitats. However, the risk
increases when infected individuals from cities travel to rural communities.
Chapter 5: Epidemiology
Dengue fever has emerged as one of the most significant vector-borne viral
infections in the world. Its global distribution has expanded dramatically over
the past five decades, affecting millions of people annually. The epidemiology
of dengue reflects not only the biology of the virus and vector but also
human activity, urbanization, and climatic factors.
Global Situation:
According to the World Health Organization (WHO, 2024):
Dengue is endemic in over 100 countries.
An estimated 390 million infections occur annually, of which around 96
million show clinical symptoms.
Approximately 70% of dengue cases occur in Asia, making it the most
affected region globally.
Severe dengue (Dengue Hemorrhagic Fever and Dengue Shock Syndrome) is
a leading cause of hospitalization and death among children in some Asian
and Latin American countries.
Outbreaks are strongly seasonal, with peaks during rainy months when
breeding sites multiply. However, climate change, globalization, and urban
crowding have extended transmission seasons and increased the
geographical range of Aedes aegypti into new areas.
Dengue in Pakistan
Pakistan has experienced recurrent dengue epidemics since the 1990s, with
major outbreaks recorded in 1994, 2005, 2011, 2017, and 2019. The disease
is now considered endemic in many parts of the country.
2011 Lahore Outbreak: One of the worst in Pakistan’s history, with over
21,000 confirmed cases and more than 350 deaths, mostly in Punjab.
2019 Outbreak: More than 47,000 cases were reported nationwide, with
Sindh and Punjab most severely affected.
2022–2023: Pakistan faced another surge following the monsoon floods, as
stagnant water created widespread breeding grounds. Thousands of cases
were reported in Karachi, Rawalpindi, and Peshawar.
The burden on the healthcare system is significant, as hospitals experience
seasonal surges in patients requiring platelet monitoring, intravenous fluids,
and hospitalization. Mortality remains relatively low when supportive care is
available, but lack of early diagnosis increases risk.
Risk Factors in Pakistan:
Several factors contribute to recurring epidemics:
1. Urbanization – Rapid population growth in cities like Karachi and Lahore
has created densely populated environments favorable for Aedes
mosquitoes.
2. Water storage practices – Frequent water shortages force people to
store water in containers, which become breeding sites.
3. Climate conditions – Monsoon rains and warm weather create ideal
mosquito habitats.
4. Public awareness – Limited knowledge of prevention measures among
communities contributes to uncontrolled spread.
WHO Statistics and Regional Trends:
South Asia, including Pakistan, India, Bangladesh, and Sri Lanka, has become
a hotspot for dengue epidemics. WHO emphasizes that the disease is now a
year-round threat in some regions, with transmission no longer restricted to
monsoon seasons. This changing trend highlights the urgent need for
integrated vector control programs and public education campaigns.
Chapter 6: Pathophysiology
Pathophysiology explains how the dengue virus interacts with the human
body and leads to disease manifestations. The severity of dengue ranges
from mild febrile illness to life-threatening conditions such as Dengue
Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS).
Understanding the mechanisms of infection and immune response is crucial
for diagnosis, treatment, and prevention.
Viral Entry and Replication:
When an infected Aedes aegypti mosquito bites a human, it injects saliva
containing the dengue virus into the bloodstream. The virus primarily targets
monocytes, macrophages, and dendritic cells.
1. The virus enters these cells via receptor-mediated endocytosis.
2. Inside the host cell, the viral RNA is released and translated to produce
viral proteins.
3. The host’s cellular machinery is hijacked to replicate viral RNA and
assemble new viral particles.
4. These new viruses spread to other cells, amplifying the infection.
This replication triggers an immune response that contributes both to viral
clearance and, in severe cases, tissue damage.
Immune Response:
The immune system plays a dual role:
Protective: Antibodies and T-cells target the virus, limiting infection.
Pathogenic: In secondary infections with a different serotype, pre-existing
non-neutralizing antibodies enhance viral entry into immune cells. This
phenomenon, known as Antibody-Dependent Enhancement (ADE), increases
viral load and is associated with severe disease outcomes.
Cytokines and inflammatory mediators are released in excess, leading to
“cytokine storm,” which damages blood vessels and causes leakage of
plasma.
Effects on Blood and Platelets:
One of the hallmarks of dengue is a drop in platelet count
(thrombocytopenia). The virus, combined with immune-mediated
destruction, reduces platelet survival and production. Low platelet levels
increase the risk of bleeding and hemorrhage.
Additionally, the infection causes plasma leakage from blood vessels, leading
to hemoconcentration and fluid accumulation in tissues. If unchecked, this
results in hypovolemic shock, a life-threatening complication.
Severe Dengue: DHF and DSS:
Dengue Hemorrhagic Fever (DHF): Characterized by high fever, bleeding
tendencies (from gums, nose, gastrointestinal tract), low platelet count, and
plasma leakage.
Dengue Shock Syndrome (DSS): Occurs when plasma leakage leads to
critically low blood pressure, multi-organ dysfunction, and, if untreated,
death.
Both severe forms are strongly associated with secondary infections due to
ADE.
Organ Involvement:
Liver: Elevated liver enzymes (ALT, AST) are common, indicating hepatic
involvement.
Kidneys: Fluid imbalance may affect kidney function.
Heart and Brain: Rarely, myocarditis and encephalitis can occur in severe
cases.
Chapter 7: Clinical Manifestations
Dengue fever presents with a wide spectrum of clinical features, ranging
from mild flu-like illness to severe, life-threatening conditions such as
Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS). The
clinical course of the disease is typically divided into three phases: febrile
phase, critical phase, and recovery phase.
1. Classical Dengue Fever:
Classical dengue, also called “breakbone fever,” is the most common form.
Symptoms usually appear 4–10 days after the mosquito bite and may last 5–
7 days. Key features include:
Sudden onset of high fever (up to 40°C / 104°F).
Severe headache, especially behind the eyes (retro-orbital pain).
Intense muscle and joint pain, leading to the term “breakbone fever.”
Nausea, vomiting, and loss of appetite.
Skin rash (appears in 50% of cases), starting as flushed skin and progressing
to a red, measles-like rash.
General fatigue and weakness.
Although uncomfortable, classical dengue is usually self-limiting and resolves
with proper supportive care.
2. Dengue Hemorrhagic Fever (DHF):
DHF is a severe form of dengue, more common in children and in patients
experiencing a secondary infection with a different serotype. It is
characterized by:
High fever, persistent for 2–7 days.
Thrombocytopenia (low platelet count).
Hemorrhagic manifestations, such as:
Nosebleeds (epistaxis).
Gum bleeding.
Easy bruising.
Gastrointestinal bleeding (black stools or vomiting blood).
Plasma leakage, leading to fluid accumulation in the chest or abdomen.
Signs of poor circulation: cold extremities, rapid pulse, and restlessness.
If untreated, DHF can progress to life-threatening complications.
3. Dengue Shock Syndrome (DSS):
DSS represents the most severe and dangerous outcome of dengue infection.
It occurs when plasma leakage leads to circulatory failure and shock.
Symptoms include:
Severe abdominal pain
Persistent vomiting.
Rapid, weak pulse.
Hypotension (low blood pressure).
Organ failure (liver, kidney, or heart).
Without prompt hospitalization and intravenous fluid management, DSS can
be fatal.
Warning Signs of Severe Dengue:
The World Health Organization (WHO) has identified several “red flag”
symptoms that indicate progression to severe dengue and require immediate
medical attention:
Bleeding gums or persistent nosebleeds.
Blood in vomit or stools.
Severe abdominal pain.
Difficulty breathing.
Rapid drop in platelet count.
Phases of Illness:
1. Febrile Phase – High fever, headache, muscle pain (2–7 days).
2. Critical Phase – Plasma leakage, risk of shock, bleeding (around day 4–
6).
3. Recovery Phase – Gradual improvement, reabsorption of fluids,
stabilization of platelet count.
Chapter 8: Diagnosis
The diagnosis of dengue fever requires a combination of clinical evaluation
and laboratory testing. Since the symptoms of dengue can overlap with other
febrile illnesses such as malaria, typhoid, and chikungunya, accurate
diagnostic methods are essential for early detection and effective
management.
1. Clinical Diagnosis:
Doctors often suspect dengue in patients presenting with:
Sudden high fever.
Severe headache, retro-orbital pain, and joint/muscle aches.
Skin rash.
Bleeding signs (gum bleeding, nosebleeds, bruises).
Recent exposure in dengue-endemic areas, especially during the rainy
season.
2. Laboratory Tests:
a) Complete Blood Count (CBC):
Leukopenia (low white blood cell count).
Thrombocytopenia (low platelet count).
Hemoconcentration (rise in hematocrit due to plasma leakage).
b) Serological Tests:
IgM antibodies – detectable from day 5 of illness, indicate recent
infection.
IgG antibodies – appear later, indicate past or secondary infection.
NS1 antigen test – detects viral protein in the first 1–7 days of fever,
useful for early diagnosis.
c) Molecular Tests:
Polymerase Chain Reaction (PCR): Identifies viral RNA with high
sensitivity and specificity. It can also distinguish between different
serotypes (DEN-1 to DEN-5).
3. Differential Diagnosis:
Since dengue shares symptoms with malaria, chikungunya,
leptospirosis, and typhoid, ruling out these conditions is crucial for
proper treatment. For example:
Malaria is confirmed through blood smears.
Typhoid is diagnosed via blood culture.
Chikungunya resembles dengue but typically causes more severe joint
pain and less bleeding.
Chapter 9: Treatment & Management
Currently, there is no specific antiviral drug available for dengue fever.
Treatment is primarily supportive and symptomatic, aimed at reducing
discomfort, preventing complications, and managing severe cases. Early
medical care can significantly lower mortality rates, especially in Dengue
Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS).
1. General Supportive Care:
Rest: Patients are advised to take complete bed rest during the acute
phase.
Hydration: Oral fluids (water, juices, ORS) are essential to prevent
dehydration caused by high fever, vomiting, and plasma leakage.
Fever Management: Paracetamol (acetaminophen) is used to control
fever and pain.
Avoid NSAIDs such as aspirin and ibuprofen, as they increase the risk
of bleeding
2. Hospitalization Criteria:
Hospital care is required when patients show warning signs such as:
Severe abdominal pain or persistent vomiting.
Bleeding gums, nosebleeds, or blood in vomit/stools.
Rapidly dropping platelet count (<20,000/μL).
Signs of shock (low blood pressure, cold extremities, restlessness).
In hospitals, patients are closely monitored for platelet count,
hematocrit levels, and blood pressure.
3. Management of Severe Dengue:
Intravenous (IV) fluids: To maintain blood pressure and compensate for
plasma leakage.
Blood transfusion: May be required in cases of severe bleeding or
dangerously low platelet levels.
Intensive care: For patients with Dengue Shock Syndrome to manage
multi-organ dysfunction.
4. Role of Vaccines:
The first licensed dengue vaccine, Dengvaxia (CYD-TDV), has shown
partial protection against the disease. However, its use is limited and
recommended only for individuals who have had a prior dengue
infection. Research is ongoing for safer and more effective vaccines.
Chapter 10: Prevention & Control
Dengue fever cannot be completely eliminated unless the mosquito vector is
controlled. Since no specific cure exists, prevention remains the most
effective strategy. Preventive measures focus on mosquito control,
environmental management, and community awareness
1. Vector Control:
The primary approach to dengue prevention is reducing mosquito
populations. This can be done through:
Elimination of breeding sites: Aedes mosquitoes breed in stagnant water.
Regular cleaning and removal of containers such as old tires, flower pots,
and water tanks reduce breeding chances.
Insecticides: Spraying insecticides (fogging) in high-risk areas can kill adult
mosquitoes.
Biological control: Introducing fish species that feed on mosquito larvae or
using bacterial agents like Bacillus thuringiensis israelensis (Bti).
2. Personal Protection:
Mosquito nets: Especially important for infants, patients, and people sleeping
outdoors.
Repellents: Application of mosquito repellent creams, sprays, or coils.
Protective clothing: Wearing long sleeves and trousers to minimize skin
exposure.
Screens: Installing window and door screens to block mosquitoes indoors.
3. Environmental Management:
Proper waste disposal: Removing garbage and solid waste that can collect
rainwater.
Water storage management: Covering water tanks and emptying them
regularly.
Community cleanliness campaigns: Collective efforts are more effective than
individual actions.
4. Awareness and Education:
Health campaigns: Governments and NGOs run programs to educate
communities about dengue prevention.
School-based education: Teaching children how to avoid mosquito bites and
remove breeding sites.
Media role: TV, radio, and social media can spread preventive messages
widely.
5. Vaccination:
The only licensed dengue vaccine, Dengvaxia, provides partial protection but
is recommended only for individuals previously infected with dengue.
Research is ongoing to develop more effective and widely applicable
vaccines.
6. Role of Government and Public Health Authorities:
Early warning systems: Monitoring weather, rainfall, and mosquito density to
predict outbreaks.
Epidemic response teams: Rapid intervention in affected areas.
Collaboration with WHO: International cooperation helps in surveillance and
resource allocation.
Chapter 11: Conclusion
Dengue fever remains one of the most significant public health challenges in
tropical and subtropical regions, particularly in countries like Pakistan. It is
caused by the dengue virus, transmitted primarily through the bite of the
Aedes aegypti mosquito. Over the years, the disease has spread widely due
to rapid urbanization, climate change, poor sanitation, and limited public
awareness.
While there is no specific antiviral treatment, early detection, proper medical
care, and supportive management can greatly reduce mortality. Preventive
measures such as mosquito control, environmental cleanliness, and personal
protection are the most effective strategies against the disease. Public health
education and community participation are also essential in reducing the
spread of dengue.
The development of vaccines such as Dengvaxia offers hope, but further
research is needed to ensure safety, effectiveness, and wider applicability.
Until then, prevention remains the cornerstone of dengue control.
In conclusion, dengue fever can be managed and its impact minimized
through collective efforts involving individuals, communities, healthcare
systems, and governments. Only by combining awareness, prevention, and
medical support can we successfully combat the growing threat of dengue.
References
World Health Organization (WHO). (2023). Dengue and severe dengue.
Retrieved from:
[Link]
dengue
World Health Organization (WHO). (2022). Dengue vaccine: WHO
position paper. Weekly Epidemiological Record, 97(25), 289–324.
Centers for Disease Control and Prevention (CDC). (2023). Dengue.
Retrieved from: [Link]
Government of Pakistan, Ministry of National Health Services,
Regulations & Coordination. (2023). National Action Plan for Dengue
Prevention and Control. Islamabad, Pakistan.
Bhatt, S., Gething, P. W., Brady, O. J., et al. (2013). The global
distribution and burden of dengue. Nature, 496(7446), 504–507.
Guzman, M. G., & Harris, E. (2015). Dengue. The Lancet, 385(9966),
453–465.
Pakistan Medical Research Council (PMRC). (2022). Annual Report on
Dengue Surveillance in Pakistan.
_______________________________________________________________